Literature DB >> 29101987

ACR Appropriateness Criteria® Ovarian Cancer Screening.

Pari V Pandharipande1, Kathryn P Lowry2, Caroline Reinhold3, Mostafa Atri4, Carol B Benson5, Priyadarshani R Bhosale6, Edward D Green7, Stella K Kang8, Yulia Lakhman9, Katherine E Maturen10, Refky Nicola11, Gloria M Salazar12, Thomas D Shipp13, Lynn Simpson14, Betsy L Sussman15, Jennifer Uyeda5, Darci J Wall16, Bradford Whitcomb17, Carolyn M Zelop18, Phyllis Glanc19.   

Abstract

There has been much interest in the identification of a successful ovarian cancer screening test, in particular, one that can detect ovarian cancer at an early stage and improve survival. We reviewed the currently available data from randomized and observational trials that examine the role of imaging for ovarian cancer screening in average-risk and high-risk women. We found insufficient evidence to recommend ovarian cancer screening, when considering the imaging modality (pelvic ultrasound) and population (average-risk postmenopausal women) for which there is the greatest available published evidence; randomized controlled trials have not demonstrated a mortality benefit in this setting. Screening high-risk women using pelvic ultrasound may be appropriate in some clinical situations; however, related data are limited because large, randomized trials have not been performed in this setting. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Copyright © 2017 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AUC; Appropriate Use Criteria; Appropriateness Criteria; CA-125; Cancer screening; Ovarian cancer; Pelvic US

Mesh:

Year:  2017        PMID: 29101987     DOI: 10.1016/j.jacr.2017.08.049

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  1 in total

1.  Radiologic-Histopathologic Correlation of Transvaginal US and Risk-reducing Salpingo-oophorectomy for Women at High Risk for Tubo-ovarian Carcinoma.

Authors:  Michelle D Sakala; Nicole E Curci; William R Masch; Mishal Mendiratta-Lala; Erica B Stein; Ashish P Wasnik; Andrew P Sciallis; Shitanshu Uppal; Mark D Pearlman; Katherine E Maturen
Journal:  Radiol Imaging Cancer       Date:  2020-11-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.